Texas Administrative Code
Title 1 - ADMINISTRATION
Part 15 - TEXAS HEALTH AND HUMAN SERVICES COMMISSION
Chapter 354 - MEDICAID HEALTH SERVICES
Subchapter D - TEXAS HEALTHCARE TRANSFORMATION AND QUALITY IMPROVEMENT PROGRAM
Division 7 - DSRIP PROGRAM DEMONSTRATION YEARS 7-8
Section 354.1713 - Category C Requirements for Performers
Universal Citation: 1 TX Admin Code ยง 354.1713
Current through Reg. 49, No. 38; September 20, 2024
(a) Requirements for hospitals and physician practices.
(1) Measure Bundle and measure
selection.
(A) A hospital or physician
practice, with the exception of those described in subparagraph (J) of this
paragraph, must select Measure Bundles from the Hospital and Physician Practice
Measure Bundle Menu of the Measure Bundle Protocol in accordance with the
requirements in subparagraphs (B) - (I) of this paragraph in the RHP plan
update for its RHP.
(B) Each
Measure Bundle is assigned a point value as described in the Measure Bundle
Protocol.
(C) A hospital or
physician practice is assigned a minimum point threshold (MPT) for Measure
Bundle selection as described in paragraphs (6) and (7) of this
subsection.
(D) A hospital or
physician practice must select Measure Bundles worth enough points to meet its
MPT in order to maintain its total valuation for DY7 and DY8. If a hospital or
physician practice does not select Measure Bundles worth enough points to meet
its MPT, its total DY7 valuation will be reduced proportionately across its RHP
Plan Update and Categories B-D funds for DY7, and its total DY8 valuation will
be reduced proportionately across its Categories B-D funds for DY8, based on
the point values of the Measure Bundles it selects.
(E) A hospital or physician practice may only
select a Measure Bundle for which its denominators for the baseline measurement
period for at least half of the required measures in the Measure Bundle have
significant volume.
(F) A hospital
or physician practice with a valuation greater than $2,500,000 per
demonstration year (DY) for DY7-8 must:
(i)
select at least one Measure Bundle with at least one required three-point
measure for which its denominator for the baseline measurement period has
significant volume; or
(ii) select
at least one Measure Bundle with at least one optional three-point measure for
which its denominator for the baseline measurement period has significant
volume, and select at least one optional three-point measure in that Measure
Bundle for which its denominator for the baseline measurement period has
significant volume.
(G) A
hospital or physician practice with an MPT of 75 must select at least one
Measure Bundle with at least one population-based clinical outcome measure as
specified in the Measure Bundle Protocol.
(H) A hospital or physician practice may only
select an optional measure in a selected Measure Bundle for which its
denominator for the baseline measurement period has significant
volume.
(I) Only a hospital with a
valuation less than or equal to $2,500,000 per DY for DY7-8 may select a
Measure Bundle identified as a rural Measure Bundle in accordance with the
requirements in the Measure Bundle Protocol.
(J) If a hospital or physician practice has a
limited scope of practice, cannot reasonably report on at least half of the
required measures in the Measure Bundle(s) appropriate for it based on its
scope of practice and community partnerships, and consequently cannot meet its
MPT for Measure Bundle selection, the hospital or physician practice may
request HHSC approval to select measures, rather than Measure Bundles, from the
Measure Bundle Protocol. The hospital or physician practice must submit a
request for such approval to HHSC prior to the RHP plan update submission, by a
date determined by HHSC. Such a request may be subject to review by the Centers
for Medicare and Medicaid Services (CMS). If HHSC and CMS, as appropriate,
approve such a request, the following requirements apply:
(i) the hospital's or physician practice's
total valuation for DY7 and DY8 may be reduced;
(ii) the hospital or physician practice must
select measures from the following menus of the Measure Bundle Protocol in
accordance with the requirements in clauses (iii) - (v) of this subparagraph in
the RHP plan update for its RHP:
(I) the
Measure Bundles on the Hospital and Physician Practice Measure Bundle
Menu;
(II) the Community Mental
Health Center Measure Menu; or
(III) the Local Health Department Measure
Menu;
(iii) each measure
in a Measure Bundle on the Hospital and Physician Practice Measure Bundle Menu,
and each measure on the Community Mental Health Center Measure Menu and the
Local Health Department Measure Menu, is assigned a point value as described in
the Measure Bundle Protocol;
(iv)
the hospital or physician practice is assigned an MPT for measure selection as
described in paragraphs (5) and (6) of this subsection; and
(v) the hospital or physician practice must
select measures worth enough points to meet its MPT in order to maintain its
total valuation for DY7 and DY8. If the hospital or physician practice does not
select measures worth enough points to meet its MPT, its total DY7 valuation
will be reduced proportionately across its RHP Plan Update and Categories B-D
funds for DY7, and its total DY8 valuation will be reduced proportionately
across its Categories B-D funds for DY8, based on the point values of the
measures it selects.
(2) DSRIP-attributed population. A hospital
or physician practice must determine its DSRIP-attributed population to be
applied to its selected Measure Bundles and measures as specified in the
Measure Bundle Protocol.
(3)
Measure Bundle valuation. A hospital or physician practice may allocate its
Category C valuation among its selected Measure Bundles in the RHP plan update
for its RHP as it chooses, provided the following requirements are met:
(A) The valuation for each selected Measure
Bundle must be greater than or equal to (the Measure Bundle point value divided
by the sum of all the selected Measure Bundles' point values) multiplied by
0.75 multiplied by the Category C valuation.
(B) The valuation for each selected Measure
Bundle without any required or selected optional three-point measures must be
less than or equal to (the Measure Bundle point value divided by the sum of all
the selected Measure Bundles' point values) multiplied by the Category C
valuation.
(C) The valuation for
each selected Measure Bundle with a required or selected optional three-point
measure must be less than or equal to (the Measure Bundle point value divided
by the sum of all the selected Measure Bundles' point values) multiplied by
1.25 multiplied by the Category C valuation.
(D) If a hospital or physician practice
allocates to a Measure Bundle a percentage of its Category C valuation that is
one percent greater than the Measure Bundle's point value as a percentage of
all the selected Measure Bundles' point values, the hospital or physician
practice must provide sufficient justification as specified in the Program
Funding and Mechanics Protocol.
(4) Measure valuation. The valuation for each
measure in a selected Measure Bundle is equal to the Measure Bundle valuation
divided by the number of measures in the selected Measure Bundle, so that the
valuations of the measures in the selected Measure Bundle are equal, with the
following exceptions:
(A) If a Measure Bundle
includes an innovative measure:
(i) the
valuation for each innovative measure in the Measure Bundle is equal to the
Measure Bundle valuation divided by the number of the measures in the Measure
Bundle subtracted by 0.5 for each innovative measure and divided by 2;
and
(ii) the valuation for each
measure in the Measure Bundle that is not an innovative measure is equal to the
Measure Bundle valuation divided by the number of measures in the Measure
Bundle subtracted by 0.5 for each innovative measure.
(B) If a hospital's or physician practice's
denominator for a required measure or numerator for a population-based clinical
outcome measure in a selected Measure Bundle for the baseline measurement
period or a performance year has no volume, the measure is removed from the
Measure Bundle, and its valuation for the applicable DY is redistributed among
the remaining measures in the Measure Bundle for which the hospital's or
physician practice's denominator for the baseline measurement period or
performance year has significant volume for the applicable DY. The valuation
for the applicable DY for each of the remaining measures in the Measure Bundle
for which the hospital's or physician practice's denominator for the baseline
measurement period or performance year has significant volume is equal to the
valuation for the Measure Bundle for the applicable DY divided by the number of
measures for which the hospital's or physician practice's denominator for the
baseline measurement period or performance year has significant volume, so that
the valuations for the applicable DY for the measures in the Measure Bundle for
which the hospital's or physician practice's denominator for the baseline
measurement period or performance year has significant volume are
equal.
(C) If a hospital's or
physician practice's denominator for a required measure or numerator for a P4R
population-based clinical outcome measure in a selected Measure Bundle for the
baseline measurement period or a performance year has insignificant volume, the
measure's milestone valuations are adjusted in accordance with subsection
(e)(2) of this section.
(5) Milestone valuation. The measure
milestones and corresponding valuations for DY7-8 are as described in
subsection (e) of this section.
(6)
MPTs for hospitals.
(A) The MPT for hospitals,
with the exception of those described in subparagraphs (B) and (C) of this
paragraph, is calculated as follows:
(i)
First, the hospital's statewide hospital factor (SHF) is equal to (.64
multiplied by (the hospital's Medicaid and uninsured inpatient days divided by
the sum of all hospitals' Medicaid and uninsured inpatient days)) plus (.36
multiplied by (the hospital's Medicaid and uninsured outpatient costs divided
by the sum of all hospitals' Medicaid and uninsured outpatient
costs)).
(ii) Second, the
hospital's statewide hospital ratio (SHR) is equal to (the hospital's DY7
valuation divided by the sum of all hospitals' DY7 valuations) divided by the
SHF.
(iii) Third, the hospital's
MPT is determined as follows:
(I) If the SHR
is less than or equal to 3, the MPT is the lesser of:
(-a-) the DY7 valuation divided by $500,000;
or
(-b-) 75.
(II) If the SHR is greater than 3 but less
than or equal to 10, the MPT is the lesser of:
(-a-) (the DY7 valuation divided by $500,000
multiplied by (the SHR divided by 3); or
(-b-) 75.
(III) If the SHR is greater than 10 and the
DY7 valuation is less than or equal to $15 million, the MPT is the lesser of:
(-a-) (the DY7 valuation divided by $500,000
multiplied by (the SHR divided by 3); or
(-b-) 40.
(IV) If the SHR is greater than 10 and the
DY7 valuation is greater than $15 million, the MPT is the lesser of:
(-a-) (the DY7 valuation divided by $500,000
multiplied by (the SHR divided by 3); or
(-b-) 75.
(B) If a hospital does not have
the data needed for the SHF calculation in paragraph (5)(A)(i) of this
subsection, or if a hospital did not participate in DSRIP during the initial
demonstration period or DY6, its MPT is the lesser of:
(i) the hospital's DY7 valuation divided by
$500,000; or
(ii) 75.
(C) If a hospital has a limited
scope of practice, cannot reasonably report on at least half of the required
measures in the Measure Bundle(s) appropriate for it based on its scope of
practice and community partnerships, and consequently cannot meet its MPT for
Measure Bundle selection, the hospital may request HHSC approval for a reduced
MPT equal to the sum of the points for all the Measure Bundles for which the
hospital could reasonably report on at least half of the required measures in
the Measure Bundle. The hospital must submit a request for such approval to
HHSC prior to the RHP plan update submission, by a date determined by HHSC.
Such a request may be subject to review by the Centers for Medicare and
Medicaid Services (CMS). If HHSC and CMS, as appropriate, approve such a
request, the hospital's total valuation for DY7 and DY8 may be
reduced.
(7) MPTs for
physician practices.
(A) The MPT for
physician practices, with the exception of those described in subparagraph (B)
of this paragraph, is the lesser of:
(i) the
physician practice's DY7 valuation divided by $500,000; or
(ii) 75.
(B) If a physician practice has a limited
scope of practice, cannot reasonably report on at least half of the required
measures in the Measure Bundles appropriate for it based on its scope of
practice and community partnerships, and consequently cannot meet its MPT for
Measure Bundle selection, the physician practice may request HHSC approval for
a reduced MPT equal to the sum of the points for all the Measure Bundles for
which the physician practice could reasonably report on at least half of the
required measures in the Measure Bundle. The physician practice must submit a
request for such approval to HHSC prior to the RHP plan update submission, by a
date determined by HHSC. Such a request may be subject to review by CMS. If
HHSC and CMS, as appropriate, approve such a request, the physician practice's
total valuation for DY7 and DY8 may be reduced.
(b) Requirements for community mental health centers (CMHCs).
(1) Measure selection.
(A) A CMHC must select measures from the
Community Mental Health Center Measure Menu of the Measure Bundle
Protocol.
(B) Each measure is
assigned a point value as described in the Measure Bundle Protocol.
(C) A CMHC is assigned an MPT for measure
selection as described in paragraph (3) of this subsection.
(D) A CMHC must select measures worth enough
points to meet its MPT in order to maintain its total valuation for DY7 and
DY8. If a CMHC does not select measures worth enough points to meet its MPT,
its total DY7 valuation will be reduced proportionately across its RHP Plan
Update and Categories B-D funds for DY7, and its total DY8 valuation will be
reduced proportionately across its Categories B-D funds for DY8, based on the
point values of the measures it selects.
(E) A CMHC may only select a measure for
which its denominator for the baseline measurement period has significant
volume.
(F) A CMHC must select at
least two measures.
(G) A CMHC with
a valuation greater than $2,500,000 per DY for DY7-8 must select at least one
three-point measure.
(2)
DSRIP-attributed population. A CMHC must determine its DSRIP-attributed
population to be applied to its selected measures as specified in the Measure
Bundle Protocol.
(3) Measure
valuation. A CMHC may allocate its Category C valuation among its selected
measures, provided the following requirements are met:
(A) The valuation for each selected measure
must be greater than or equal to (the Category C valuation divided by the
number of selected measures) multiplied by 0.75.
(B) The valuation for each selected one-point
measure must be less than or equal to the Category C valuation divided by the
number of selected measures.
(C)
The valuation for each selected three-point or four-point measure must be less
than or equal to (the Category C valuation divided by the number of selected
measures) multiplied by 1.25.
(D)
If a CMHC allocates to a measure a percentage of its Category C valuation that
is one percent greater than the Category C valuation divided by the number of
selected measures, the CMHC must provide sufficient justification as specified
in the Program Funding and Mechanics Protocol.
(4) Milestone valuation. The measure
milestones and corresponding valuations for DY7-8 are as described in
subsection (e) of this section.
(5)
MPTs. A CMHC's MPT is the lesser of:
(A) the
CMHC's DY7 valuation divided by the standard point valuation ($500,000);
or
(B) 40.
(c) Requirements for local health departments (LHDs).
(1) Measure selection.
(A) An LHD must select measures from:
(i) the Local Health Department Measure Menu
of the Measure Bundle Protocol; or
(ii) its DY6 Category 3 pay-for-performance
(P4P) measures.
(B) An
LHD may not select the same measure from both the Local Health Department
Measure Menu of the Measure Bundle Protocol and its DY6 Category 3 P4P
measures.
(C) If an LHD's DY6
Category 3 P4P measures include multiple versions of the same measure, the LHD
may select multiple versions of that measure, but the points associated with
that measure will only count once toward the LHD's MPT.
(D) Each measure on the Local Health
Department Measure Menu is assigned a point value as described in the Measure
Bundle Protocol.
(E) Each LHD DY6
Category 3 P4P measure is assigned a point value as described in the Measure
Bundle Protocol.
(F) An LHD is
assigned an MPT for measure selection as described in paragraph (4) of this
subsection.
(G) An LHD must select
measures worth enough points to meet its MPT in order to maintain its total
valuation for DY7 and DY8. If an LHD does not select measures worth enough
points to meet its MPT, its total DY7 valuation will be reduced proportionately
across its RHP Plan Update and Categories B-D funds for DY7, and its total DY8
valuation will be reduced proportionately across its Categories B-D funds for
DY8, based on the point values of the measures it selects.
(H) An LHD may only select a measure for
which its denominator for the baseline measurement period has significant
volume.
(I) An LHD must select at
least two measures.
(J) An LHD with
a valuation of more than $2,500,000 per DY for DY7-8 must select at least one
three-point measure.
(2)
DSRIP-attributed population. An LHD must determine its DSRIP-attributed
population to be applied to its selected measures as specified in the Measure
Bundle Protocol.
(3) Measure
valuation. An LHD may allocate its Category C valuation among its selected
measures, provided the following requirements are met:
(A) The valuation for each selected measure
must be greater than or equal to (the Category C valuation divided by the
number of selected measures) multiplied by 0.75.
(B) The valuation for each selected one-point
measure must be less than or equal to the Category C valuation divided by the
number of selected measures.
(C)
The valuation for each selected three-point or four-point measure must be less
than or equal to (the Category C valuation divided by the number of selected
measures) multiplied by 1.25.
(D)
If an LHD allocates to a measure a percentage of its Category C valuation that
is one percent greater than the Category C valuation divided by the number of
selected measures, the LHD must provide sufficient justification as specified
in the Program Funding and Mechanics Protocol.
(4) Milestone valuation. The measure
milestones and corresponding valuations for DY7-8 are as described in
subsection (e) of this section.
(5)
MPTs. An LHD's MPT is the lesser of:
(A) the
LHD's DY7 valuation divided by the standard point valuation ($500,000);
or
(B) 20.
(d) Measurement periods.
(1) Baseline measurement periods. The
baseline measurement period for a measure is calendar year 2017 with the
following exceptions:
(A) the baseline
measurement period for a DY6 Category 3 P4P measure selected by a LHD is
DY6;
(B) a performer that
demonstrates good cause may request for a measure to have a shorter baseline
measurement period consisting of no fewer than six months as specified in the
Program Funding and Mechanics Protocol and HHSC guidance;
(C) a performer that demonstrates good cause
may request for a measure to have a delayed baseline measurement period that
ends no later than September 30, 2018, as specified in the Program Funding and
Mechanics Protocol and HHSC guidance; and
(D) any other exception specified in the
Measure Bundle Protocol or one of its appendices.
(2) Performance measurement periods. The
performance measurement periods for a P4P measure are as follows:
(A) Performance Year (PY) 1 for a measure is
calendar year 2018 unless otherwise specified in the Measure Bundle Protocol or
one of its appendices.
(B) PY2 for
a measure is calendar year 2019 unless otherwise specified in the Measure
Bundle Protocol or one of its appendices.
(C) PY3 for a measure is calendar year 2020
unless otherwise specified in the Measure Bundle Protocol or one of its
appendices.
(3) Reporting
measurement periods. The reporting measurement periods for a pay-for-reporting
(P4R) measure are as follows unless otherwise specified in the Measure Bundle
Protocol:
(A) Reporting Year (RY) 1 for a
measure is DY7; and
(B) RY 2 for a
measure is DY8.
(e) Measure milestones.
(1) The milestones and corresponding
valuations for DY7-8 are as follows, with the exceptions specified in
paragraphs (2) and (3) of this subsection:
(2) If a
hospital's or physician practice's denominator for a required measure in a
selected Measure Bundle for the baseline measurement period or a performance
measurement period has insignificant volume, the valuation for the measure's
goal achievement milestone for the DY is redistributed among the goal
achievement milestones for the measures in the Measure Bundle for which the
hospital's or physician practice's denominator for the baseline measurement
period or performance measurement period has significant volume for the
applicable DY. The valuations for the goal achievement milestones for the
measures in the Measure Bundle for which the hospital's or physician practice's
denominator has significant volume for the DY are calculated as follows:
(A) the valuation for the DY7 goal
achievement milestone is equal to 50 percent of the valuation for the Measure
Bundle divided by the number of measures in the Measure Bundle for which the
hospital's or physician practice's denominator has significant volume, so that
the valuations for the DY7 goal achievement milestones for the measures in the
Measure Bundle for which the hospital's or physician practice's denominator has
significant volume are equal; and
(B) the valuation for the DY8 goal
achievement milestone is equal to 75 percent of the valuation for the Measure
Bundle divided by the number of measures in the Measure Bundle for which the
hospital's or physician practice's denominator has significant volume, so that
the valuations for the DY8 goal achievement milestones for the measures in the
Measure Bundle for which the hospital's or physician practice's denominator has
significant volume are equal.
(3) Measures with multiple parts. Some P4P
measures have multiple parts, as described in the Program Funding and Mechanics
Protocol and Measure Bundle Protocol.
(A) A
measure with multiple parts has one baseline reporting milestone per DY, one PY
reporting milestone per DY, and multiple goal achievement milestones per
DY.
(B) The valuation for each
measure part's goal achievement milestone is equal to the measure's total goal
achievement milestone valuation divided by the number of measure parts so that
the measure parts' goal achievement milestone valuations are equal.
(C) All measure parts' baseline reporting
milestones must be reported during the same reporting period.
(D) All measure parts' PY reporting
milestones must be reported during the same reporting period.
(E) Each measure part's goal achievement
milestone will have its own goal. Therefore, the percent of goal achieved, as
described in §RSA 354.1719 of this division
(relating to Disbursement of Funds) will be determined for a measure part's
goal achievement milestone independently of the percent of goal achieved for
the other measure parts' goal achievement milestones.
(4) A performer must report a baseline for a
measure, and HHSC must approve the reported baseline for reporting purposes,
before a performer can report PY1 (or PY2 if HHSC approved the use of a delayed
baseline measurement period for the measure).
(A) A performer must adhere to measure
specifications and maintain a record of any variances approved by HHSC prior to
reporting a baseline for a measure.
(B) HHSC's approval of a reported baseline
for reporting purposes does not constitute approval for a performer to report a
measure outside measure specifications. If at any point HHSC or the independent
assessor finds that a performer is reporting a measure outside measure
specifications, reporting milestone payment and goal achievement milestone
payment may be withheld or recouped while the performer works to bring
reporting into compliance with measure specifications.
(5) A performer must report a P4P measure's
reporting milestone and goal achievement milestone for a given PY during the
same reporting period, with exceptions for P4P measures with a delayed baseline
measurement period.
(f) Measure eligible denominator population.
(1)
Each Measure Bundle for hospitals and physician practices has a target
population as specified in the Measure Bundle Protocol.
(2) A measure's eligible denominator
population must include all individuals served by the performer's system during
a given measurement period that are included in the performer's
DSRIP-attributed population and the target population for a measure for
hospitals and physician practices, and that meet the measure's specifications
as specified in the Measure Bundle Protocol.
(3) A performer may not use a
performer-specific facility, co-morbid condition, age, gender, or
race/ethnicity subset not otherwise specified in the Measure Bundle
Protocol.
(4) Reporting milestones.
A performer must report its performance on a measure for the all-payer,
Medicaid-only, and Low-income Uninsured-only (LIU-only) payer types to be
eligible for payment of the measure's reporting milestones.
(A) A performer that demonstrates good cause
may request in the RHP plan update submission to be exempted from reporting its
performance on a measure for the Medicaid-only payer type or the LIU-only payer
type as specified in the Program Funding and Mechanics Protocol.
(B) A performer that demonstrates good cause
may submit a RHP plan update modification request to HHSC to be exempted from
reporting its performance on a measure for the Medicaid-only payer type or the
LIU-only payer type as specified in the Program Funding and Mechanics
Protocol.
(5) Goal
achievement milestones. Payment for a P4P measure's goal achievement milestone
is based on the performer's performance on the measure for the MLIU payer type.
(A) A performer that demonstrates good cause
may request in the RHP plan update submission that payment for a P4P measure's
goal achievement milestone be based on the performer's performance on the
measure for the all-payer, Medicaid-only, or LIU-only payer type as specified
in the Program Funding and Mechanics Protocol.
(B) A performer that demonstrates good cause
may submit a RHP plan update modification request to HHSC to change the payer
type on which payment for a P4P measure's goal achievement milestone is based
as specified in the Program Funding and Mechanics Protocol.
(g) Methodology for P4P measure goal setting.
(1) A P4P measure's
goals are set as an improvement over the baseline.
(2) A P4P measure is designated as either
Quality Improvement System for Managed Care (QISMC) or Improvement over Self
(IOS) as specified in the Measure Bundle Protocol. A P4P measure designated as
QISMC has a defined High Performance Level (HPL) and Minimum Performance Level
(MPL) based on national or state benchmarks.
(3) A P4P measure's goals for its goal
achievement milestones are set as follows:
(4) A
performer may request HHSC approval in the RHP plan update to use a numerator
of zero for certain P4P measures for the baseline measurement period, as
described in the Program Funding and Mechanics Protocol and Measure Bundle
Protocol. If a performer receives HHSC approval to use a numerator of zero for
a P4P measure for the baseline measurement period, the goal for the DY7 goal
achievement milestone will be equal to the 75th percentile, and the goal for
the DY8 goal achievement milestone will be equal to a 10% gap closure between
the 75th percentile and the HPL, as described in the Measure Bundle
Protocol.
(h) Carry forward policy.
(1) Carry forward of
reporting. If a performer does not report a measure's baseline reporting
milestone or performance year reporting milestone during the first reporting
period after the end of the milestone's measurement period, the performer may
request to carry forward reporting of the milestone to the next reporting
period.
(2) Carry forward of
achievement.
(A) A performer may request to
carry forward achievement of a measure's goal achievement milestone so that the
DY7 goal achievement milestone may be achieved in PY1 or PY2, and the DY8 goal
achievement milestone may be achieved in PY2 or PY3, with the exception
described in subparagraph (B) of this paragraph.
(B) If a measure has a delayed baseline
measurement period, a performer will carry forward achievement of its goal
achievement milestone so that the DY7 goal achievement milestone may be
achieved in PY2.
(C) The performer
must report the carried forward achievement of a measure's goal achievement
milestone during the first reporting period after the end of the milestone's
carried forward measurement period.
Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.